# "Prolonging the Therapeutic Life Span of Artemisinin-based Combination Therapies (ACT) in Bagamoyo District, Tanzania"

> **NCT03241901** · PHASE4 · COMPLETED · sponsor: **Muhimbili University of Health and Allied Sciences** · enrollment: 280 (actual)

## Conditions studied

- Malaria,Falciparum

## Interventions

- **DRUG:** Artemether-Lumefantrine Tab 20-120mg
- **DRUG:** Primaquine Phosphate 0.25 mg/kg
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03241901
- **Lead sponsor:** Muhimbili University of Health and Allied Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-27
- **Primary completion:** 2017-12-28
- **Final completion:** 2018-02-17
- **Target enrollment:** 280 (ACTUAL)
- **Last updated:** 2018-03-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03241901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03241901, ""Prolonging the Therapeutic Life Span of Artemisinin-based Combination Therapies (ACT) in Bagamoyo District, Tanzania"". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03241901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*